It's My Life
It's My Life It's My Life Hemophilia Village
Information for Health Care Professionals
Product Information Indication/Safety Information Tell a Friend Site Map
It's My Life

Home
About Hemophilia
Programs & Services
Treating Hemophilia
About BeneFIX
About ReFacto
Personal Stories
News & Resources
News
News Archive
Events Calendar
Online Resources
Publications
Wyeth & Hemophilia
Wyeth
News Archive

 

IMMEDIATE RELEASE

Wyeth Pharmaceuticals Awards $73,000 in Scholarships to the Hemophilia Community
St. Davids, Pa. (October 2002) - Wyeth Pharmaceuticals has announced the winners of its annual hemophilia scholarship program - the Soozie Courter Sharing a Brighter Tomorrow Hemophilia Scholarship Program. Now in its fifth year, the program is awarding twelve $5,000 undergraduate scholarships, two $5,000 graduate scholarships, and three $1,000 vocational scholarships. The following individuals are scholarship recipients for the 2002-2003 academic year.

Undergraduate
  • Barham Bratton (Swarte, La.) - Louisiana Tech University
  • Tom Budescu (Champaign, Ill.) - University of North Carolina, Chapel Hill
  • Yuri Chumak (Toronto, Ont.) - University of Western Ontario
  • Mark Guest (St. Louis, Mo.) - Washington University
  • Bryon Jasper (Houma, La.) - TBD
  • Daniel Jensen (Decatur, Ill.) - Bradley University
  • Joshua Lunior (Accord, N.Y.) - Ulster County Community College
  • Geoffrey Merl (Dayton, Ohio) - Ohio State University
  • Christopher Paige (Portsmouth, Va.) - TBD
  • Richard Strodtman (Glasgow, Mo.) - University of Missouri, Columbia*
  • Vladisiav Vilenchik (Chicago, Ill.) - Illinois Institute of Technology
  • Craig Wright (Franklin, Tenn.) - Lipscomb University*
Graduate
  • Caesar Pascual (Carson, Calif.) - TBD
  • Beau Ward (Llano, Texas) - Trinity University*
Vocational
  • Israel Ambriz (Watsonville, Calif.) - Heald College
  • Willie Brasley (Hopkins, S.C.) - Midlands Technical College

"In our fifth year of the scholarship program, we are very pleased to continue our tradition of supporting education in the hemophilia community, and recognizing academic achievement," says Bernard Poussot, President, Wyeth Pharmaceuticals.

Scholarship Background
To receive an application for the Soozie Courter Sharing a Brighter Tomorrow Hemophilia Scholarship Program 2003-2004 academic year, please call 888-322-6010. To be eligible for the scholarships, students must have either hemophilia A or B, and be either a high school senior or have a graduate equivalency diploma (GED) or currently be enrolled in an accredited junior college, college (undergraduate or graduate), or vocational school. The scholarship applicants are required to provide a personal essay or statement, information on their academic achievements, and letters of recommendation. A committee of hemophilia health care providers reviews the applications and selects scholarship winners. More than 125 individuals from 33 states, Puerto Rico, and Canada applied to the scholarship program this year. The scholarships are dedicated to the memory of Soozie Courter, RN, and her contributions to the hemophilia community. During her career in the pharmaceutical industry, Soozie worked on developing products to treat hemophilia. By naming the scholarships in her honor, the Hemophilia Group at Wyeth recognizes Courter's compassion and interest in all issues related to the scientific advancement of hemophilia research.

Hemophilia is a rare, inherited blood clotting disorder for which there currently is no cure. People with hemophilia are deficient in the key proteins that are vital in the clotting cascade to prevent bleeding - factor VIII (hemophilia A) or factor IX (hemophilia B). Both forms of hemophilia are characterized by spontaneous hemorrhages or prolonged bleeding, typically into joints and soft tissue. In the United States, nearly 4,000 people have hemophilia B and between 15,000 and 17,000 people have hemophilia A. Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, cardiovascular disease, central nervous system, inflammation, hemophilia, oncology and vaccines. Wyeth (NYSE:WYE) is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

# # #

*Indicates a repeat scholarship winner.

Back to News Archives


   
Privacy Policy | Terms and Conditions
The information on this site is only intended for residents of the United States.
© 2007, Wyeth Pharmaceuticals Inc., Philadelphia, PA 19101
119533-01